XML 36 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Note 14 - Segment Data
12 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
Note
14.
  Segment Data
 
Segment information is prepared on the same basis that our management reviews financial information for operational decision-making purposes. We have
four
operating segments: Sterilization and Disinfection Control, Instruments, Cold Chain Monitoring and Cold Chain Packaging.  When determining the reportable segments, we aggregated operating segments based on their similar economic and operating characteristics. The following tables set forth our segment information:
 
 
   
Year Ended March 31, 2019
 
   
Sterilization
and
Disinfection
Control
   
Instruments
   
Cold Chain
Monitoring
   
Cold Chain
Packaging
   
Total
 
Revenues (1)
  $
46,297
    $
36,125
    $
13,806
    $
6,907
    $
103,135
 
Gross profit
  $
31,861
    $
22,866
    $
5,582
    $
607
    $
60,916
 
Reconciling items (2)
   
 
     
 
     
 
     
 
     
(52,293
)
Earnings before income taxes
   
 
     
 
     
 
     
 
    $
8,623
 
 
   
Year Ended March 31, 2018
 
   
Sterilization
and
Disinfection
Control
   
Instruments
   
Cold Chain
Monitoring
   
Cold Chain
Packaging
   
Total
 
Revenues (1)
  $
43,260
    $
34,104
    $
12,978
    $
5,837
    $
96,179
 
Gross profit
  $
29,333
    $
20,395
    $
3,854
    $
1,037
    $
54,619
 
Reconciling items (2)
   
 
     
 
     
 
     
 
     
(54,318
)
Earnings before income taxes
   
 
     
 
     
 
     
 
    $
301
 
 
   
Year Ended March 31, 2017
 
   
Sterilization
and
Disinfection
Control
   
Instruments
   
Cold Chain
Monitoring
   
Cold Chain
Packaging
   
Total
 
Revenues (1)
  $
38,635
    $
34,405
    $
12,584
    $
8,041
    $
93,665
 
Gross profit
  $
25,674
    $
21,037
    $
4,557
    $
1,971
    $
53,239
 
Reconciling items (2)
   
 
     
 
     
 
     
 
     
(38,943
)
Earnings before income taxes
   
 
     
 
     
 
     
 
    $
14,296
 
 
 
(
1
)
Intersegment revenues are
not
significant and are eliminated to arrive at consolidated totals.
 
(
2
)
Reconciling items include selling, general and administrative, research and development, impairment loss on goodwill and long-lived assets, legal settlement, and other expenses.
 
The following table sets forth total assets by operating segment:
 
   
March 31,
2019
   
March 31,
2018
 
Sterilization and Disinfection Control
  $
74,230
    $
83,452
 
Instruments
   
30,911
     
33,479
 
Cold Chain Monitoring
   
32,179
     
30,796
 
Cold Chain Packaging
   
1,590
     
7,091
 
Corporate and administrative
   
17,857
     
9,283
 
Total
  $
156,767
    $
164,101
 
 
All long-lived assets are located in the United States except for
$5,649,
$1,427,
and
$15,762
which are associated with our French, Canadian and German subsidiaries, respectively.
 
Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows:
 
   
Year Ended March 31,
 
   
2019
   
2018
   
2017
 
United States
  $
64,828
    $
56,998
    $
52,989
 
Foreign
   
38,307
     
39,181
     
40,676
 
Total
  $
103,135
    $
96,179
    $
93,665
 
 
No
foreign country exceeds
10%
 of total revenues.